Telix Pharmaceuticals (NasdaqGS:TLX) FY Conference Transcript

Telix Pharmaceuticals (NasdaqGS:TLX) FY Conference February 26, 2026 04:40 PM ET Company ParticipantsChristian Behrenbruch - Managing Director and Group Chief Executive OfficerConference Call ParticipantsJeff Jones - Managing Director and Senior Analyst, BiotechnologyJeff JonesGood afternoon, everyone. Welcome back to the afternoon session of Oppenheimer's Annual Healthcare Conference. I'm Jeff Jones, one of the analysts on the biotech team here. I am delighted to be joined by Christian Behrenbruch, CEO of ...